Memphis Pharmaceuticals is trading at 52.25 as of the 23rd of December 2024. This is a 0.89 percent down since the beginning of the trading day. The stock's lowest day price was 52.15. Memphis Pharmaceuticals has hardly any chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 24th of September 2024 and ending today, the 23rd of December 2024. Click here to learn more.
Although Memphis Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Memphis Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Memphis Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Memphis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Memphis Pharmaceuticals by comparing valuation metrics with similar companies.